Seven months after Dumbass Trump accused the pharmaceutical industry of "getting away with murder,"
he is busy lining the pockets of large pharmaceutical companies
worldwide by giving them more power to charge higher prices overseas.
Their price monopolies are likely to be extended under a draft executive order
promising "greater intellectual property protection" in multilateral
and bilateral trade agreements. The North American Free Trade Agreement,
for example, has already been pegged to harmonize foreign intellectual property standards to reflect those found in the United States. Canada, it seems, will be the first target of U.S. indoctrination.
No comments:
Post a Comment